Company
Headquarters: Guangzhou, China
Employees: 10,714
CN¥11.51 Billion
CNY as of Jan. 1, 2025
US$1.58 Billion
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $219.88 B |
| Danaher | $177.43 B |
| Siemens Healthineers AG | $59.19 B |
| Agilent Technologies, Inc. | $43.57 B |
| Lonza Group Ltd | $41.66 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Guangzhou Kingmed Diagnostics Group Co., Ltd. operates as a third-party medical laboratory company. The company offers medical diagnostic information, clinical trial, lab, food and hygiene testing, health management, medical cold chain logistics, and scientific research services, as well as vitro diagnostics, healthcare big data, artificial intelligence, and forensic testing services. It operates 37 testing laboratories in mainland of China and Hong Kong. The company was founded in 2003 and is headquartered in Guangzhou, China.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | CN¥7.85 B |
| EBITDA | CN¥738.8 M |
| Gross Profit TTM | CN¥2.73 B |
| Profit Margin | 2.05% |
| Operating Margin | 0.02% |
| Quarterly Revenue Growth | -16.60% |
Guangzhou Kingmed Diagnostics Group Co. Ltd has the following listings and related stock indices.
Stock: SSE: 603882 wb_incandescent